Marcellusi A, Bini C, Fioravanti L, Ripoli S, Morelli P. Cost-effectiveness of Brentuximab Vedotin plus chemotherapy as frontline treatment of systemic anaplastic large cell lymphoma in Italy. Grhta [Internet]. 2025 Apr. 30 [cited 2025 May 5];12(1):106-17. Available from: https://journals.aboutscience.eu/index.php/grhta/article/view/3306